Pulmonx Corporation (LUNG)

Pulmonx Market Cap

Pulmonx has a market cap or net worth of $348.37 million as of May 17, 2024. Its market cap has decreased by -28.35% in one year.

• Market Cap: 348.37M
• Enterprise Value: 272.58M
• 1-Year Change: -28.35%
• Ranking: #3253
• Category: Small-Cap
• Stock Price: $9.00

Market Cap Chart

Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $616.87M to $348.37M, a decrease of -43.53%. That is a compound annual growth rate of -14.57%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	349.30M	-0.57%
May 16, 2024	351.30M	-2.90%
May 15, 2024	361.80M	4.63%
May 14, 2024	345.80M	1.59%
May 13, 2024	340.40M	4.29%
May 10, 2024	326.40M	-3.89%
May 9, 2024	339.60M	-0.70%
May 8, 2024	342.00M	-7.54%
May 7, 2024	369.90M	2.69%
May 6, 2024	360.20M	-5.51%
May 3, 2024	381.20M	5.45%
May 2, 2024	361.50M	21.51%
May 1, 2024	297.50M	1.43%
Apr 30, 2024	293.30M	1.49%
Apr 29, 2024	289.00M	2.99%
Apr 26, 2024	280.60M	-0.25%
Apr 25, 2024	281.30M	-2.93%
Apr 24, 2024	289.80M	0.28%
Apr 23, 2024	289.00M	1.33%
Apr 22, 2024	285.20M	-1.45%
Apr 19, 2024	289.40M	0.14%
Apr 18, 2024	289.00M	0.94%
Apr 17, 2024	286.30M	0.14%
Apr 16, 2024	285.90M	-0.69%
Apr 15, 2024	287.90M	-5.33%

View and export this data all the way back to 2020. Sign Up Today.

Related Stocks

Company	Market Cap
Amarin Corporation	358.53M
biote	357.33M
Aura Biosciences	355.72M
Immutep	354.28M
Precigen	353.39M
Jasper Therapeutics	347.42M
Zynex	345.71M
Solid Biosciences	343.50M